Califf Aims To Publish FDA’s Rx-To-OTC Proposed Rule, If Confirmed

By Beth Wang / January 11, 2022 at 2:18 PM
FDA chief-nominee Robert Califf says that, if confirmed to lead the agency, he would work to publish FDA’s highly anticipated, long-delayed regulatory proposal to allow certain prescription drugs be sold over the counter. The agency is under pressure to publish the proposal, which HHS says is key to the Biden administration’s efforts to lower health care prices and increase access to drugs. The Senate health committee is expected to vote Thursday (Jan. 13) to forward Califf’s confirmation to the Senate...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.